Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00060684
Status:
COMPLETED
Last Update Posted:
2015-01-19
First Post:
2003-05-09
Brief Title:
Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkins Lymphoma
Sponsor:
CTI BioPharma
Organization:
CTI BioPharma
Organization Data
Organization:
CTI BioPharma
Class:
INDUSTRY
Study ID:
AZA I-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CTI BioPharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Gabriella Camboni MD
Old Organization:
Cell Therapeutics Inc